BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34183180)

  • 1. Computed tomography (CT) scan identified necrosis, but is it a reliable single parameter for discerning between malignant and benign adrenocortical tumors?
    Garay-Lechuga D; Pérez-Soto RH; Hernández-Acevedo JD; Butrón-Hernández D; Sierra-Salazar M; Pantoja-Millán JP; Herrera MF; Velázquez-Fernández D
    Surgery; 2022 Jan; 171(1):104-110. PubMed ID: 34183180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric adrenocortical neoplasms: can imaging reliably discriminate adenomas from carcinomas?
    Flynt KA; Dillman JR; Davenport MS; Smith EA; Else T; Strouse PJ; Caoili EM
    Pediatr Radiol; 2015 Jul; 45(8):1160-8. PubMed ID: 25794486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case studies in hypertension. Adrenal carcinoma.
    Handler J
    J Clin Hypertens (Greenwich); 2003; 5(5):355-8. PubMed ID: 14564138
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenocortical oncocytic carcinoma misdiagnosed as adrenal cortical adenoma.
    Li Y; Li P; Tao FK; Li JM
    Asian J Surg; 2024 May; 47(5):2475-2476. PubMed ID: 38302362
    [No Abstract]   [Full Text] [Related]  

  • 5. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocortical adenoma containing a fat component: CT and MR image evaluation.
    Sato N; Watanabe Y; Saga T; Mitsudo K; Dohke M; Minami K
    Abdom Imaging; 1995; 20(5):489-90. PubMed ID: 7580794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in surgical pathology of adrenocortical tumours.
    Erickson LA
    Histopathology; 2018 Jan; 72(1):82-96. PubMed ID: 29239032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography.
    Thomas AJ; Habra MA; Bhosale PR; Qayyum AA; Ahmed K; Vicens R; Elsayes KM
    Abdom Radiol (NY); 2018 Nov; 43(11):3101-3108. PubMed ID: 29671009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Diagnostic Approach to Adrenocortical Tumors.
    Hodgson A; Pakbaz S; Mete O
    Surg Pathol Clin; 2019 Dec; 12(4):967-995. PubMed ID: 31672302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diagnostic approach to adrenal cortical lesions.
    McNicol AM
    Endocr Pathol; 2008; 19(4):241-51. PubMed ID: 19089656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.
    Ichijo T; Ueshiba H; Nawata H; Yanase T
    Endocr J; 2020 Feb; 67(2):141-152. PubMed ID: 31694993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registry.
    Petersenn S; Richter PA; Broemel T; Ritter CO; Deutschbein T; Beil FU; Allolio B; Fassnacht M;
    Eur J Endocrinol; 2015 Apr; 172(4):415-22. PubMed ID: 25599706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to a previously published case: recurrence of invasive adrenocortical tumor after excision of atypical adenoma.
    Outwater EK; Mitchell DG; Rubenfeld IG
    Radiology; 1997 Feb; 202(2):531-2. PubMed ID: 9015085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?
    Pohlink C; Tannapfe A; Eichfeld U; Schmidt F; Führer D; Paschke R; Koch CA
    J Endocrinol Invest; 2004 Jun; 27(6):565-9. PubMed ID: 15717655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children.
    Chatterjee G; DasGupta S; Mukherjee G; Sengupta M; Roy P; Arun I; Datta C; Mishra PK; Banerjee S; Chatterjee U
    Pediatr Surg Int; 2015 Jun; 31(6):563-71. PubMed ID: 25895073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large degenerated adrenal adenomas: radiologic-pathologic correlation.
    Newhouse JH; Heffess CS; Wagner BJ; Imray TJ; Adair CF; Davidson AJ
    Radiology; 1999 Feb; 210(2):385-91. PubMed ID: 10207419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
    Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
    Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of adrenocortical cancer.
    Lehmann T; Wrzesinski T
    Cancer Genet; 2012 Apr; 205(4):131-7. PubMed ID: 22559973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
    Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical tumours: high CT attenuation value correlates with eosinophilia but does not discriminate lipid-poor adenomas from malignancy.
    Pennanen M; Raade M; Louhimo J; Sane T; Heiskanen I; Arola J; Haglund C
    J Clin Pathol; 2013 Dec; 66(12):1076-80. PubMed ID: 23908452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.